Tamir Bental

ORCID: 0000-0002-1490-740X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Coronary Interventions and Diagnostics
  • Acute Myocardial Infarction Research
  • Cardiac Valve Diseases and Treatments
  • Cardiac Imaging and Diagnostics
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Infective Endocarditis Diagnosis and Management
  • Cardiovascular Function and Risk Factors
  • Cardiac Arrhythmias and Treatments
  • Cardiac pacing and defibrillation studies
  • Vascular Procedures and Complications
  • Atrial Fibrillation Management and Outcomes
  • Cerebrovascular and Carotid Artery Diseases
  • Heart Failure Treatment and Management
  • Climate Change and Health Impacts
  • Pulmonary Hypertension Research and Treatments
  • Cardiac, Anesthesia and Surgical Outcomes
  • Aortic aneurysm repair treatments
  • Cardiac Health and Mental Health
  • Acute Kidney Injury Research
  • Venous Thromboembolism Diagnosis and Management
  • Cardiac electrophysiology and arrhythmias
  • Air Quality and Health Impacts
  • Transplantation: Methods and Outcomes
  • Urban Green Space and Health
  • Aortic Disease and Treatment Approaches

Rabin Medical Center
2016-2025

Tel Aviv University
2015-2024

Lev Hasharon Hospital
2024

Gifu Heart Center
2023

Parallax Research (United States)
2021

The University of Queensland
2020

Duke Medical Center
2016

Massachusetts General Hospital
2015

Harvard University
2015

Arthur M. Sackler Gallery
2011

Cancer patients are mostly excluded from percutaneous coronary intervention (PCI) clinical trials and oncologic history is lacking most PCI registries. Thus, little known about the outcomes following among cancer survivors. Our aim was to examine prevalence long-term outcome of survivors a large patient cohort.We retrospectively integrated analyzed cardiovascular data 12 785 consecutive who underwent between April 2004 October 2014. were compared with pair-matched cancer-naive...

10.1097/mca.0000000000000429 article EN Coronary Artery Disease 2016-09-13

Background Exposure to traffic-related air pollution (TRAP) is considered have a carcinogenic effect. The authors previously reported nonsignificant association between TRAP and cancer risk in relatively small cohort of myocardial infarction survivors. This study assessed whether exposure associated with subsequent large coronary patients. Methods & results Consecutive patients undergoing percutaneous interventions major medical centre central Israel from 2004 2014 were followed for through...

10.1177/2047487318760892 article EN European Journal of Preventive Cardiology 2018-02-27

Abstract Objective: To assess the value of ratio between contrast medium volume and glomerular filtration rate (CMGFRr) for prediction development contrast‐induced nephropathy (CIN) mortality in patients with ST‐segment elevation acute myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PCI). Background: Renal function is a strong predictor outcome STEMI. CIN may complicate course PCI these patients. Methods: The study population included all 871 consecutive...

10.1002/ccd.22828 article EN Catheterization and Cardiovascular Interventions 2010-10-14

Background Intravenous dobutamine administration improves short-term hemodynamics in patients with severe congestive heart failure (CHF). However, the clinical benefit of periodic remains controversial. Objective To evaluate efficacy intermittent refractory CHF. Methods Nineteen New York Heart Association class III IV, ischemia-induced CHF participated this double-blind, placebo-controlled study. All received intravenous or placebo over a 24-hour period every 2 to 3 weeks for 6 months. They...

10.1016/s0009-9236(98)90092-3 article EN Clinical Pharmacology & Therapeutics 1998-06-01

Background About a decade past the first transcatheter aortic valve implantation ( TAVI ), data are limited regarding temporal trends accompanying its evolution from novel technology to mainstream therapy. We evaluated these in large multicenter registry. Hypothesis is changing and improving with time. Methods Patients who underwent between January 2008 December 2014 at 3 high‐volume Israeli centers were divided into 5 time quintiles according procedure date. Outcomes analyzed reported Valve...

10.1002/clc.22632 article EN Clinical Cardiology 2016-10-26

Abstract Background American and European valvular heart disease guidelines suggest considering aortic valve surgery in patients with severe regurgitation (AR) progressive increase left ventricle (LV) end diastolic diameter (LVEDD) into the range or decrease LV function. Surprisingly, there are almost no studies that actually examined systematically rate of change over time these widely used parameters clinical practice AR. Purpose determine LVEDD, ventricular systolic (LVESD) fractional...

10.1093/ehjci/jeae333.116 article EN European Heart Journal - Cardiovascular Imaging 2025-01-01

AimsThe pathogenesis of late coronary stent thrombosis may be related to impaired arterial healing. Endothelial progenitor cells (EPCs) have been shown play an important role in repair and re-endothelialization following vascular injury. We hypothesized that patients who develop reduced or dysfunctional EPCs, aimed compare EPC level function experienced vs. matched controls.

10.1093/eurheartj/ehq184 article EN European Heart Journal 2010-06-11

<b><i>Objectives:</i></b> Patients with antiphospholipid antibody syndrome (APS) have an increased risk of atherothrombotic complications. There are limited data regarding the outcome patients APS who undergo percutaneous coronary intervention (PCI). Accordingly, we aimed to assess long-term outcomes these patients. <b><i>Methods:</i></b> Nineteen underwent PCI between years 2003 and 2008 were compared 380 had undergone during same period (PCI...

10.1159/000338347 article EN Cardiology 2012-01-01

Abstract Background The last decade, regarded as the DES era in PCI, has witnessed significant advances management of coronary disease. We aimed to assess temporal trends practice and outcome percutaneous intervention (PCI) during drug eluting stent (DES) era. Methods analyzed 18,641 consecutive PCI's performed between January 2004 December 2016, distinguished by procedural date ( Q 1 : 2004–2006, n = 4,865; 2 2007–2009, 4,977; 3 2010–2012, 4,230; 4 2013–2016, 4,569). Results At...

10.1002/ccd.27375 article EN Catheterization and Cardiovascular Interventions 2017-10-13

Accumulated experience combined with technological advancements in percutaneous coronary interventions (PCI) over the past four decades, has led to a gradual increase PCI utilization and complexity. We aimed investigate temporal trends complexity outcomes of complex (C-PCI) our institution.We analyzed 20,301 consecutive procedures performed 12-year period. C-PCI was defined as procedure involving at least one following: Chronic total occlusion (CTO), left main (LM), bifurcation or saphenous...

10.3389/fcvm.2022.913588 article EN cc-by Frontiers in Cardiovascular Medicine 2022-06-24

Abstract Aims : Given the anecdotal reports and case series suggesting that drug‐eluting coronary stents [DES] may be still vulnerable to thrombosis after six months, we sought assess this risk in patients undergoing non‐cardiac surgery months stenting. Methods Results Linking Rabin Medical Centre interventional cardiology database with its surgical database, identified 78 who underwent DES placement subsequently [after months] had noncardiac [15‐vascular, 37‐ abdominal genitourinary...

10.1002/ccd.22158 article EN Catheterization and Cardiovascular Interventions 2009-05-19

To conduct a risk-adjusted gender-based analysis of clinical outcomes following drug-eluting stent (DES) versus bare metal (BMS) implantation in patients with coronary artery disease.We compared total mortality rate, myocardial infarction, and event-free survival (defined as freedom from death, infarction and/or repeat revascularisation) consecutive cohort 7,662 undergoing percutaneous intervention at our institution, including 1,835 (25.4%) women. Follow-up was six months to 6.2 years...

10.4244/eijv7i9a167 article EN EuroIntervention 2012-01-01

Background Patients who have had an acute coronary syndrome ( ACS ) are at increased risk of recurrent cardiovascular events; however, paradoxically, high-risk patients may derive the greatest benefit from guideline-recommended therapies often undertreated. The aim our study was to examine management, clinical outcomes, and temporal trends after stratified by Thrombolysis in Myocardial Infarction (TIMI) score for secondary prevention, a recently validated tool that incorporates 9 factors....

10.1161/jaha.118.009885 article EN cc-by-nc-nd Journal of the American Heart Association 2018-09-16
Coming Soon ...